V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006592 | 280008191 | 1.75 | null | Palliative (P) | 2015-01-28 | 2015-02-01 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 280022641 | LIPOSOMAL DOXORUBICIN |
| 280006593 | 280004035 | 1.65 | 137 | Adjuvant (A) | null | 2015-05-12 | Paclitaxel 7 day | null | null | 280022665 | CARBOPLATIN + VINORELBINE |
| 280006594 | 280004036 | 1.55 | null | null | 2015-07-14 | 2015-07-14 | Ipilimumab | N | N | 280022670 | MELPHALAN |
| 280006595 | 280004036 | 1.68 | 39.6 | Curative (C) | null | 2015-02-09 | Pazopanib | N | N | 280022670 | IVA |
| 280006596 | 280004036 | 1.65 | 63.2 | Disease modification (D) | 2015-12-12 | 2015-12-12 | ECX | N | N | 280022670 | BCG |
| 280006597 | 280004037 | 1.63 | null | Neo-adjuvant (N) | 2018-10-02 | 2018-10-07 | IMATINIB | N | N | 280022764 | IFOSFAMIDE |
| 280006598 | 280004038 | 1.59 | null | Neo-adjuvant (N) | 2016-08-12 | 2016-08-25 | LENALIDOMIDE | Y | N | 280022772 | CARBO + FLUOROURACIL |
| 280006599 | 280004039 | null | 69.3 | Palliative (P) | 2016-10-28 | 2016-10-28 | Doxorubicin + Olaratumab | Y | N | 280022800 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280006600 | 280004040 | 1.83 | 68.9 | Neo-adjuvant (N) | 2017-11-25 | 2017-12-09 | Capecitabine + Oxaliplatin 21day | 02 | N | 280022830 | CARBO + FLUOROURACIL |
| 280006601 | 280004041 | 1.68 | 60 | Palliative (P) | 2013-08-11 | 2013-08-11 | Enzalutamide | N | N | 280022848 | ABIRATERONE |
| 280006602 | 280008193 | 1.59 | 82.5 | Neo-adjuvant (N) | 2017-08-07 | 2017-08-10 | Paclitaxel 7 day | 02 | N | 280022869 | CARBO + FLUOROURACIL |
| 280006603 | 280004042 | 1.89 | 63.8 | Palliative (P) | 2016-11-23 | 2018-03-11 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 280022899 | CISPLATIN + FLUOROURACIL + RT |
| 280006604 | 280004043 | 1.7 | 87.9 | Palliative (P) | 2014-02-28 | 2014-03-20 | Ipilimumab | N | N | 280022951 | DOCETAXEL + GEMCITABINE |
| 280006605 | 280004043 | 1.64 | 49.3 | Palliative (P) | 2017-02-18 | 2017-02-18 | FCiSt | 2 | N | 280022951 | PEMBROLIZUMAB |
| 280006606 | 280004044 | null | 93.4 | Palliative (P) | 2016-06-24 | 2016-06-25 | IVA | N | N | 280022962 | CETUXIMAB + CISPLATIN + FU |
| 280006607 | 280004045 | 1.65 | 54.5 | Palliative (P) | null | 2014-07-21 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | N | N | 280022975 | SIROLIMUS |
| 280006608 | 280004046 | 1.68 | 0 | Neo-adjuvant (N) | 2013-12-31 | 2019-04-13 | Capecitabine | 02 | Y | 280022981 | FEC + DOCETAXEL |
| 280006609 | 280004047 | null | 71.2 | Palliative (P) | 2017-11-24 | 2017-11-30 | Cisplatin + Topotecan | N | N | 280022986 | KESTREL TRIAL |
| 280006610 | 280004047 | 1.69 | null | Curative (C) | 2018-03-10 | 2018-03-13 | Carbo F | 02 | N | 280022986 | EURO-EWING |
| 280006611 | 280004048 | 0 | 64 | Palliative (P) | 2014-12-08 | 2014-12-14 | LANREOTIDE | 02 | N | 280023013 | CYCLOPHOSPHAMIDE |
| 280006612 | 280004049 | 0 | 91 | Neo-adjuvant (N) | 2018-10-21 | 2018-10-21 | Everolimus 10mg | N | N | 280023039 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280006613 | 280004050 | 1.74 | 66 | Curative (C) | 2015-12-06 | 2015-12-21 | CISPLATIN + ETOPOSIDE | N | Y | 280023080 | IVA |
| 280006614 | 280004051 | 0 | 100.9 | Palliative (P) | 2017-03-25 | 2017-04-18 | Doxorubicin + Olaratumab | Y | Y | 280023084 | CARBOPLATIN + PEMETREXED |
| 280006615 | 280004051 | 1.67 | 104.4 | Palliative (P) | 2017-11-10 | 2017-11-08 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 280023084 | EVEROLIMUS |
| 280006616 | 280004052 | 1.84 | 73.2 | null | 2016-09-11 | 2016-09-26 | Capecitabine | N | N | 280023104 | CISPLATIN + ETOPOSIDE |
| 280006617 | 280004053 | 1.75 | null | Adjuvant (A) | 2014-09-14 | 2014-09-15 | Topotecan (intravenous) | N | N | 280023129 | RMS 2005 TRIAL |
| 280006618 | 280004054 | 1.6 | 0 | Curative (C) | 2017-12-07 | 2017-12-24 | Doxorubicin + Olaratumab | N | N | 280023135 | VIDE |
| 280006619 | 280004055 | 1.63 | 99.4 | Curative (C) | 2018-02-18 | 2018-03-07 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | N | 280023147 | VIDE |
| 280006620 | 280004055 | 1.7 | null | Palliative (P) | 2015-12-27 | 2016-01-23 | Cisplatin + Pemetrexed | N | Y | 280023147 | PEMBROLIZUMAB |
| 280006621 | 280004056 | 1.61 | 59.3 | Palliative (P) | 2013-08-11 | 2013-08-11 | OCTREOTIDE | N | N | 280023173 | LIPOSOMAL DOXORUBICIN |
| 280006622 | 280004057 | 1.65 | null | null | 2018-07-11 | 2018-07-12 | OCTREOTIDE | N | null | 280023187 | MELPHALAN |
| 280006623 | 280004057 | null | 101.4 | Palliative (P) | 2017-12-31 | 2018-01-04 | Paclitaxel 7 day | Y | N | 280023187 | PACLITAXEL |
| 280006624 | 280004058 | 1.83 | 67.9 | Neo-adjuvant (N) | 2014-04-15 | 2014-04-15 | Doxorubicin + Olaratumab | N | N | 280023280 | VIDE |
| 280006625 | 280004059 | 1.76 | 87.1 | Curative (C) | 2018-08-25 | 2018-09-15 | CARBOPLATIN + FLUOROURACIL | N | N | 280023285 | DARS TRIAL |
| 280006626 | 280004060 | 1.52 | null | Disease modification (D) | 2018-01-28 | 2018-03-04 | Doxorubicin + Olaratumab | N | N | 280023286 | BCG |
| 280006627 | 280004061 | 1.63 | null | Palliative (P) | 2018-03-09 | 2018-04-09 | Oxaliplatin + Modified de Gramont | N | N | 280023299 | DOCETAXEL |
| 280006628 | 280004061 | 1.6 | 21.2 | Curative (C) | 2017-08-02 | 2017-08-05 | Oxaliplatin + Modified de Gramont | 02 | N | 280023299 | VIDE |
| 280006629 | 280004061 | 1.71 | null | Palliative (P) | 2017-05-18 | 2017-05-19 | OCTREOTIDE | 02 | N | 280023299 | CETUXIMAB + CISPLATIN + FU |
| 280006630 | 280004062 | 1.65 | 133.6 | Palliative (P) | 2014-03-21 | 2014-03-28 | Liposomal Doxorubicin 50mg/m2 | N | N | 280023330 | DOCETAXEL |
| 280006631 | 280004063 | 1.66 | null | Curative (C) | 2013-05-09 | 2013-05-09 | Etoposide + Ifosfamide (3 days) | null | N | 280023358 | CISPLATIN + DOCETAXEL |
| 280006632 | 280004063 | 1.88 | 76 | Palliative (P) | 2016-07-30 | 2016-08-24 | Docetaxel | N | N | 280023358 | VIDE |
| 280006633 | 280004063 | 1.8 | 77.3 | Palliative (P) | 2017-01-09 | 2017-02-02 | CISPLATIN + ETOPOSIDE | N | Y | 280023358 | CYCLOPHOSPHAMIDE |
| 280006634 | 280004064 | 1.67 | 53 | Palliative (P) | 2014-08-08 | 2014-10-27 | FLUOROURACIL + OXALIPLATIN | 02 | N | 280023385 | PACLITAXEL |
| 280006635 | 280004065 | null | 71.8 | Palliative (P) | 2017-04-13 | 2017-04-23 | Oxaliplatin + Modified de Gramont | 99 | null | 280023443 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 280006636 | 280004066 | 1.59 | 54.9 | Palliative (P) | 2014-03-04 | 2014-05-27 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 280023465 | CARBO + FLUOROURACIL |
| 280006637 | 280008201 | null | null | Curative (C) | 2015-06-19 | 2015-06-22 | CISPLATIN + FLUOROURACIL + RT | null | null | 280023503 | VDC |
| 280006638 | 280008201 | null | 83 | Neo-adjuvant (N) | null | 2017-10-18 | Sunitinib | null | null | 280023503 | CHOP R |
| 280006639 | 280008201 | 1.85 | 66.8 | Palliative (P) | 2014-04-12 | 2014-04-12 | Capecitabine (21days) + Carboplatin | N | N | 280023503 | DOXORUBICIN + OLARATUMAB |
| 280006640 | 280004067 | 1.7 | null | Palliative (P) | 2014-05-02 | 2014-05-10 | VAI (Ifos 3g/m2) | N | N | 280023533 | LIPOSOMAL DOXORUBICIN |
| 280006641 | 280004068 | 1.8 | null | Palliative (P) | 2017-12-15 | 2017-12-24 | Dacarbazine | N | N | 280023535 | CISPLATIN + VINORELBINE |